Are Investors Undervaluing Afya (AFYA) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Afya Limited (AFYA) Q3 2025 Earnings Call Transcript
Afya Limited ( AFYA ) Q3 2025 Earnings Call November 12, 2025 5:00 PM EST Company Participants Renata Couto - Investor Relations Executive Manager Virgilio Deloy Gibbon - Chief Executive Officer Luis Andre Blanco - Chief Financial Officer Conference Call Participants Lucca Marquezini - Itaú Corretora de Valores S.A., Research Division Lucas Nagano - Morgan Stanley, Research Division Marcelo Santos - JPMorgan Chase & Co, Research Division Mirela Rodrigues de Oliveira - BofA Securities, Research Division Renan Prata - Citigroup Inc. Exchange Research Presentation Renata Couto Investor Relations Executive Manager Thank you for joining us for Afya's conference call.
Afya (AFYA) Q3 Earnings Beat Estimates
Afya (AFYA) came out with quarterly earnings of $0.38 per share, beating the Zacks Consensus Estimate of $0.32 per share. This compares to earnings of $0.32 per share a year ago.
Afya's Multiple Is Back To Reasonable Levels, But Market Saturation Is Real
Afya's Q2 2025 results were solid, but the stock faces headwinds from market saturation and regulatory changes in Brazil's medical education sector. Valuation is now more attractive after a 20%+ price drop, but risks from lower pricing power, increased competition, and new quality exams remain significant. The company is shifting capital allocation toward buybacks and dividends, signaling fewer expansion opportunities and a focus on shareholder returns.
Afya Limited (AFYA) Q2 2025 Earnings Call Transcript
Afya Limited (NASDAQ:AFYA ) Q2 2025 Earnings Conference Call August 13, 2025 5:00 PM ET Company Participants Luis Andre Carpintero Blanco - Chief Financial Officer Virgilio Deloy Capobianco Gibbon - Chief Executive Officer Conference Call Participants Flavio Yoshida - BofA Securities, Research Division Lucca Generali Marquezini - Itaú Corretora de Valores S.A., Research Division Marcelo Peev dos Santos - JPMorgan Chase & Co, Research Division Mauricio I Cepeda - Morgan Stanley, Research Division Renan Prata - Citigroup Inc. Exchange Research Samuel Campos Alves - Banco BTG Pactual S.A.
Best Growth Stocks to Buy for August 6th
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today August 6th:
Best Growth Stocks to Buy for August 4th
PRIM, AFYA and JBL made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 4, 2025.
Best Growth Stocks to Buy for July 31st
AFYA, ROAD and PAAS made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 31, 2025.
Best Growth Stocks to Buy for July 29th
AFYA, ROAD and PAAS made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 29, 2025.
AFYA vs. LOPE: Which Stock Should Value Investors Buy Now?
Investors looking for stocks in the Schools sector might want to consider either Afya (AFYA) or Grand Canyon Education (LOPE). But which of these two stocks is more attractive to value investors?
Is Afya (AFYA) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Best Growth Stocks to Buy for July 25th
AFYA, ROAD and PAAS made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 25, 2025.
